Early experience of COVID-19 in 2 heart transplant recipients: Case reports and review of treatment options
Open Access
- 22 May 2020
- journal article
- review article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 20 (10), 2916-2922
- https://doi.org/10.1111/ajt.15982
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleasemBio, 2018
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesScience Translational Medicine, 2017
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesJournal of Medicinal Chemistry, 2017
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replicationProceedings of the National Academy of Sciences of the United States of America, 2008
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.2003
- Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patientsLiver Transplantation, 2003
- Tacrolimus whole blood concentrations correlate closely to side‐effects in renal transplant recipientsBritish Journal of Clinical Pharmacology, 1999